Effectiveness of Intranasal Insulin for the Treatment of Olfactory Dysfunction: A Systematic Review
ORL · 2026
DOI: 10.1159/000550990 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift ORL, 2026. Verfasst von Atheer Ali Al-Talhi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Otorhinolaryngology Head and Neck Surgery Department, Dr. Soliman Fakeeh Hospital, Jeddah, Saudi Arabia. Hauptthemen laut MEDLINE: Olfaction Disorders, Insulin, Hypoglycemic Agents.
Abstract (Originalsprache)
Introduction
To assess the effectiveness and safety of Intranasal Insulin (INI) for the treatment of Olfactory Dysfunction (OD) in patients with anosmia and/or hyposmia compared to placebo or no treatment.
Methods
We searched four databases: Medline, Scopus, Directory of Open Access Journals (DOAJ), and Springer Nature Journals. The study protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO) (ID: CRD42023456891). The protocol design was in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Participants with hyposmia or anosmia, aged 18 years or older, were included. Patients with an altered sense of smell due to anatomical malformations, trauma, neurodegenerative diseases, surgery, or intranasal lesions were excluded.
Results
Five studies that enrolled 131 participants were included. There were 131 participants, of whom 63 were male and 68 were female. The participants’ ages ranged from 16 to 56 years old. Almost all studies had a dose of 40 IU, but one study had different doses for different participants. Glycemic assessment was performed in three studies, which showed a very slight decrease in glucose, except in one study in which the drop in glucose reached 10.4 mg/dl. All studies agreed that there was an improvement in olfactory function after INI administration.
Conclusion
This systematic review concluded that INI can be an effective treatment option for patients with OD. However, conducting further well-designed clinical trials is highly recommended to establish robust clinical recommendations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Otorhinolaryngology Head and Neck Surgery Department, Dr. Soliman Fakeeh Hospital, Jeddah, Saudi Arabia.
- College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.
- King Abdullah International Medical Research Center (KAIMRC), Jeddah, Saudi Arabia.
- Division of Otolaryngology - Head and Neck Surgery, Department of Surgery, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
- College of Medicine, Jazan University, Jazan, Saudi Arabia, sumaily.i@gmail.com.
- ENT Department, King Fahd Central Hospital, Jizan, Saudi Arabia, sumaily.i@gmail.com.
Zitieren
APA
Al-Talhi, A. A., AlRajhi, B., Almalki, A. H. S., Alqazenli, M., AlGhamdi, M. A., Munhish, F. A., & Sumaily, I. (2026). Effectiveness of Intranasal Insulin for the Treatment of Olfactory Dysfunction: A Systematic Review. ORL. https://doi.org/10.1159/000550990
Vancouver
Al-Talhi AA, AlRajhi B, Almalki AHS, Alqazenli M, AlGhamdi MA, Munhish FA, et al. Effectiveness of Intranasal Insulin for the Treatment of Olfactory Dysfunction: A Systematic Review. ORL. 2026. doi:10.1159/000550990
BibTeX
@article{AlTalhi2026,
author = {Al-Talhi, Atheer Ali and AlRajhi, Bassam and Almalki, Abdulaziz Hamed S and Alqazenli, Mohamed and AlGhamdi, Muhnnad Abdulaziz and Munhish, Fadi Abdu and Sumaily, Ibrahim},
title = {Effectiveness of Intranasal Insulin for the Treatment of Olfactory Dysfunction: A Systematic Review},
journal = {ORL},
year = {2026},
doi = {10.1159/000550990}
}
EUVIMED